UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063573
Receipt number R000072751
Scientific Title Feasibility Study of an Upper Limb Rehabilitation Program Using a Shoulder Rehabilitation Support App for Patients After Breast Cancer Surgery
Date of disclosure of the study information 2026/11/09
Last modified on 2026/11/09 20:09:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Feasibility Study of an Upper Limb Rehabilitation Program Using a Shoulder Rehabilitation Support App for Patients After Breast Cancer Surgery

Acronym

BC-ULR Feasibility Study

Scientific Title

Feasibility Study of an Upper Limb Rehabilitation Program Using a Shoulder Rehabilitation Support App for Patients After Breast Cancer Surgery

Scientific Title:Acronym

BC-ULR Feasibility Study

Region

Japan


Condition

Condition

Breast Cancer

Classification by specialty

Breast surgery Rehabilitation medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The primary objective of this study is to evaluate the feasibility of an upper limb rehabilitation program using a shoulder rehabilitation support app in patients after breast cancer surgery. Feasibility will be assessed primarily by the proportion of patients achieving a predefined level of adherence to self-directed exercises, based on exercise completion records in the app. Secondary outcomes, including shoulder range of motion, upper limb function, pain, quality of life (QOL), activities of daily living (ADL), and safety, will also be explored.

Basic objectives2

Others

Basic objectives -Others

Feasibility assessment of an app-based upper limb rehabilitation program for patients after breast cancer surgery

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Proportion of patients achieving a predefined level of adherence to the prescribed app-based self-directed exercise program

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Patients after breast cancer surgery will receive an upper limb rehabilitation program using a shoulder rehabilitation support app. The app provides exercise videos, functions for recording pain and other patient-reported information, and a function for recording exercise completion. Participants will perform self-directed exercises using the videos and record completion by pressing a completion button in the app. During outpatient visits, therapists will assess shoulder range of motion, pain, and other relevant clinical findings and adjust the exercise program according to each patient's condition. The intervention period will be approximately 8 weeks after surgery.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1. Patients aged 18 years or older at the time of obtaining informed consent.

2. Patients with breast cancer who are scheduled to undergo or have undergone breast-conserving surgery or total mastectomy with axillary lymph node dissection at the National Cancer Center Hospital East, excluding those undergoing immediate breast reconstruction.

3. Patients who have experience using a smartphone or who can receive assistance from family members in using a smartphone.

4. Patients who have received sufficient information about the study and have voluntarily provided written informed consent to participate.

5. Patients who are able to read and write Japanese.

Key exclusion criteria

1. Patients with a history of fracture, trauma, or surgery involving the shoulder joint on the operated side.

2. Patients who develop postoperative wound dehiscence or surgical site infection.

3. Patients who have difficulty using the app due to severe dementia or other cognitive impairments.

4. Patients deemed unsuitable for participation in the study by the principal investigator for any other reason.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name motoki
Middle name meta
Last name tanaka

Organization

National Cancer Center Hospital East

Division name

Department of Rehabilitation Medicine

Zip code

2778577

Address

6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan

TEL

0471331111

Email

mottanak@east.ncc.go.jp


Public contact

Name of contact person

1st name motoki
Middle name
Last name tanaka

Organization

National Cancer Center Hospital East

Division name

Department of Rehabilitation Medicine

Zip code

2778577

Address

6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan

TEL

0471331111

Homepage URL


Email

mottanak@east.ncc.go.jp


Sponsor or person

Institute

National Cancer Center Japan

Institute

Department

Personal name



Funding Source

Organization

Logos&Pathos Consulting

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Cancer Center Japan

Address

6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan

Tel

0471331111

Email

irst@ncc.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 10 Month 06 Day

Date of IRB


Anticipated trial start date

2026 Year 12 Month 01 Day

Last follow-up date

2027 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 11 Month 09 Day

Last modified on

2026 Year 11 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072751